| Phase 19 trials |
|
Phase 1
|
NCT04844775 |
Aug 2022 → Sep 2024 |
— |
ANRS, Emerging Infectious Diseases |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT04842682 |
Mar 2021 → Nov 2024 |
— |
ANRS, Emerging Infectious Diseases |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT03391375 |
Mar 2017 → Jan 2018 |
HIV infectious disease |
EuroVacc Foundation |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT02376582 |
Sep 2014 → Jan 2016 |
HIV infectious disease |
EuroVacc Foundation |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT02207920 |
Jul 2014 → Dec 2015 |
HIV infectious disease |
National Institute of Allergy and Infectious Diseases (NIAID) |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT01783977 |
Apr 2013 → Sep 2014 |
HIV infectious disease |
National Institute of Allergy and Infectious Diseases (NIAID) |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT01799954 |
Aug 2012 → Dec 2014 |
HIV infectious disease |
HIV Vaccine Trials Network |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT01927835 |
? → Jan 2017 |
HIV infectious disease |
National Institute of Allergy and Infectious Diseases (NIAID) |
Withdrawn
|
No outcome recorded
|
|
Phase 1
|
NCT01964937 |
? → Apr 2014 |
HIV infectious disease |
National Institute of Allergy and Infectious Diseases (NIAID) |
Withdrawn
|
No outcome recorded
|
| Phase 21 trial |
|
Phase 2
|
NCT04066881 |
Dec 2020 → Dec 2024 |
HIV infectious disease |
MRC/UVRI and LSHTM Uganda Research Unit |
Completed
|
No outcome recorded
|
| Comparator or background therapy1 trial |
|
Phase 1
|
NCT02997969 Comparator |
Jun 2016 → Jul 2018 |
HIV infectious disease |
National Institute of Allergy and Infectious Diseases (NIAID) |
Completed
|
No outcome recorded
|